Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection
Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Mobeen H. Rathore, Mark H. Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis, Henry H. Bernstein, David W. Kimberlin, Sarah S. Long, H. Cody Meissner, Marc A. Fischer, Bruce G. Gellin, Richard L. GormanLucia H. Lee, R. Douglas Pratt, Jennifer S. Read, Joan L. Robinson, Marco Aurelio Palazzi Safadi, Jane F. Seward, Jeffrey R. Starke, Geoffrey R. Simon, Tina Q. Tan, Joseph A. Bocchini, W. Robert Morrow, Larry K. Pickering, Geoffrey L. Rosenthal, Dan L. Stewart, Almut Winterstein, Jennifer M. Frantz, Shawn L. Ralston, Allan S. Lieberthal, Brian K. Alverson, Jill E. Baley, Anne M. Gadomski, David W. Johnson, Michael J. Light, Nizar F. Maraqa, Eneida A. Mendonca, Kieran J. Phelan, Joseph J. Zorc, Danette Stanko-Lopp, Sinsi Hernández-Cancio, Mark A. Brown, Ian Nathanson, Elizabeth Rosenblum, Stephen Sayles, Caryn Davidson
Dive into the research topics of 'Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection'. Together they form a unique fingerprint.